oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-79
SponsorAesculap AG
About this trial
Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.
Eligibility criteria
Qualifiers
Patient age ≤ 80 years
Indication for a total knee replacement with one of the variants
Written informed consent
Willingness and mental ability to participate at the long-term follow-up examinations
Disqualifiers
Contraindications acc. to the Instructions for Use (IFU)
Patient age < 18 years
Known pregnancy
BMI > 40
Trial design
Treatments tested in this trial
- oneKNEE®
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov